The polycystic ovary syndrome does not predict further miscarriage in Japanese couples experiencing recurrent miscarriages

American Journal of Reproductive Immunology

Volumn 61, Issue 1, 2009, Pages 62-67

  Sugiura Ogasawara, Mayumi ^a   Sato, Takeshi ^a   Suzumori, Nobuhiro ^a   Kitaori, Tamao ^a   Kumagai, Kyoko ^a   Ozaki, Yasuhiko ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

FSH; LH; Polycystic ovary syndrome; Recurrent miscarriages; Testosterone

Indexed keywords

CLOMIFENE; LUTEINIZING HORMONE; METFORMIN; TESTOSTERONE;

ADULT; ARTICLE; CAUSAL ATTRIBUTION; CONTROLLED STUDY; FEMALE; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; HUMAN; HYPERANDROGENISM; INFERTILITY; JAPANESE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OBESITY; OVARY POLYCYSTIC DISEASE; PREDICTION; PREGNANCY OUTCOME; PRIORITY JOURNAL; RECURRENT ABORTION; SPONTANEOUS ABORTION; TESTOSTERONE BLOOD LEVEL;

ABORTION, HABITUAL; ADULT; FAMILY CHARACTERISTICS; FEMALE; HUMANS; JAPAN; MALE; POLYCYSTIC OVARY SYNDROME; PREGNANCY;

EID: 57749193749     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2008.00662.x     Document Type: Article

References (31)

1. Sugiura-Ogasawara M, Ozaki Y, Sato T, Suzumori N, Suzumori K: Poor prognosis of recurrent aborters with either maternal or paternal reciprocal translocation. Fertil Steril 2004; 81:367-373.
2. Farquharson RG, Pearson JF, John L: Lupus anticoagulant and pregnancy management. Lancet 1984; 28:228-229.
3. Raga F, Bauset C, Remohi J, Bonilla-Musoles F, Simon C, Pellicer A: Reproductive impact of congenital Mullerian anomalies. Hum Reprod 1997; 12:2277-2281.
4. Carp H, Feldman B, Oelsner G, Schiff E: Parental karyotype and subsequent live births in recurrent miscarriage. Fertil Steril 2004; 81:1296-1301.
5. Nelen W, Steegers E, Eskes T, Blom H: Genetic risk factors for unexplained recurrent pregnancy loss. Lancet 1996; 350:861.
6. Rey E, Kahn SR, David M, Shrier I: Thrombophilic disorders and fetal loss: A meta-analysis. Lancet 2003; 361:901-908.
7. Herz-Picciotto I, Samuels SJ: Incidence of early pregnancy loss of pregnancy. N Engl J Med 1998; 319:1483-1484.
8. Aoki K, Kajiura S, Matsumoto Y, Ogasawara M, Yagami Y, Gleicher N: Elevated natural killer cell activity at preconception as a predictor of a subsequent miscarriage: A prospective cohort study. Lancet 1995; 345:1342-1344.
9. Ogasawara MS, Aoki K, Katano K, Ozaki Y, Suzumori K: Factor XII but not protein C, protein S, antithrombin III or factor XIII as a predictor of recurrent miscarriage. Fertil Steril 2001; 75:916-919.
10. Sugiura-Ogasawara M, Nozawa K, Nakanishi T, Hattori Y, Ozaki Y: Complement as a predictor of further miscarriage in couples with recurrent miscarriages. Hum Reprod 2006; 21:2711-2714.
11. Hattori Y, Nakanishi T, Ozaki Y, Nozawa K, Sato T, Sugiura-Ogasawara M: Uterine cervical inflammatory cytokines, interleukin-6 and -8, as predictors of miscarriage in recurrent cases. Am J Reprod Immunol 2007; 58:350-357.
12. Homburg R, Armar NA, Eshel A, Adams J, Jacobs HS: Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ 1988; 297:1024-1026.
13. Sagle M, Bishop K, Ridley N, Alexander FM, Michel M, Bonney RC, Beard RW, Franks S: Recurrent early miscarriage and polycystic ovaries. BMJ 1988; 297:1027-1028.
14. Clifford K, Rai R, Watson H, Regan L: An informative protocol for the investigation of recurrent miscarriage: Preliminary experience of 500 consecutive cases. Hum Reprod 1995; 3:19-25.
15. Rai R, Backos M, Rushworth F, Regan L: Polycystic ovaries and recurrent miscarriage-a reappraisal. Hum Reprod 2000; 15:612-615.
16. Regan L, Owen EJ, Jacobs HS: Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet 1990; 336:1141-1144.
17. Watson H, Kiddy DS, Hamilton-Fairley D, Scanlon MJ, Barnard C, Collins WP, Bonney RC, Franks S: Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage. Hum Reprod 1993; 8:829-833.
18. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus Workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycyctic ovary syndrome. Fertil Steril 2004; 81:19-25.
19. Kaufman RP, Baker VM, DiMarino P, Gimpel T, Castracane VD: Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: A comparison of two distinct populations. Am J Obstet Gynecol 2002; 187:1362-1369.
20. Carmina E, Koyama T, Chang L, Stanczyk FZ, Lobo RA: Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol 1992; 167:1807-1812.
21. The Japan Society of Obstetrics and Gynecology. New diagnostic criteria of polycystic ovary syndrome in Japanese population. Acta Obstet Gynecol Japonica 2007; 59:868-888.
22. Matsuura E, Igarashi Y, Yasuda T, Triplett DA, Koike T: Anticardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994; 179:457-462.
23. Ogasawara M, Aoki K, Matsuura E, Sasa H, Yagami Y: Antiβ2glycoprotein I antibodies and lupus anticoagulant in patients with recurrent pregnancy loss; Prevalence and clinical association. Lupus 1996; 5:587-592.
24. Cocksedge KA, Li TC, Saravelos SH, Metwally M: A reappraisal of the role of polycystic ovary syndrome in recurrent miscarriage. Reprod Biomed Online 2008; 17:151-160.
25. Glueck CJ, Sieve L, Zhu B, Wang P: Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome. Metabolism 2006; 55:345-352.
26. Iwasa T, Matsuzaki T, Minakuchi M, Tanaka N, Shimizu F, Hirata Y, Kuwahara A, Yasui T, Maegawa M, Irahara M: Diagnostic performance of serum total testosterone for Japanese patients with polycystic ovary syndrome. Endocr J 2007; 54:233-238.
27. Ludwig M, Finas DF, Al-Hasani S, Diedrich K, Ortmann O: Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycyctic ovarian syndrome patients. Hum Reprod 1999; 14:354-358.
28. Weghofer A, Munne S, Chen S, Barad D, Gleicher N: Lack of association between polycystic ovary syndrome and embryonic aneuploidy. Fertil Steril 2007; 88:900-905.
29. Palomba S, Orio F Jr, Falbo A, Manguso F, Russo T, Cascella T, Tolino A, Carmina E, Colao A, Zullo F: Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90:4068-4074.
30. Ogasawara M, Aoki K, Okada S, Suzumori K: Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril 2000; 73:300-304.
31. Moll E, Bossuyt PM, Korevaar JC, Lambalk CB, van der Veen F: Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: Randomised double blind clinical trial. BMJ 2006; 332:7556.